background

Upadacitinib Hemihydrate

Upadacitinib Hemihydrate Watermark

Upadacitinib Hemihydrate

CAT No:CL-UDCN-27
CAS No:2050057-56-0
Mol.F:C17H19F3N6O : 1/2(H2O)
Mol.Wt.:380.4 : 1/2(18.0)
Chemical Name:(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide Hemihydrate
Inventory Status:Custom synthesis

This impurity is related to Upadacitinib Hemihydrate is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

Upadacitinib Hemihydrate is used as a reference standard in analytical research. It ensures consistency of formulations.

Chemical Name:(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide Hemihydrate
Country of Origin: India
Product Category: Impurity Reference Standard
API NAME: Upadacitinib
Molecular Formula: C17H19F3N6O : 1/2(H2O)
Molecular Weight: 380.4 : 1/2(18.0)
Storage: Store in a cool, dry place.

Document